ALS Investment Fund
Status
ACTIVE
Global HQ
Amsterdam, Netherlands
Countries of investment
- USA
Investment stages
- Seed
- Series A
- Series B
Industries
- Biotechnology
About
ALS Investment Fund invests in biotech companies focusing on neurodegenerative diseases like ALS, Alzheimer's disease, and Parkinson’s disease. They emphasize companies with strong founders and cuttingedge technologies, with a preference for those having platform approaches relevant to multiple diseases or multiple drugs in clinical development. Their portfolio includes companies that have proven the basic science behind their approaches and are working towards a value inflection point. Notable investments include Amylyx, Orphazyme, Emulate, Verge Genomics, Apic Bio, Prilenia, QurAlis, and Bloom Science.
ALS Investment Fund invests in biotech companies focusing on neurodegenerative diseases like ALS, Alzheimer's disease, and Parkinson’s disease. They emphasize companies with strong founders and cuttingedge technologies, with a preference for those having platform approaches relevant to multiple diseases or multiple drugs in clinical development. Their portfolio includes companies that have proven the basic science behind their approaches and are working towards a value inflection point. Notable investments include Amylyx, Orphazyme, Emulate, Verge Genomics, Apic Bio, Prilenia, QurAlis, and Bloom Science.
Investment Thesis
They invest in biotech companies developing drugs in a specialized area of disease: neurodegeneration, with a particular focus in ALS.
Team
Felix von Coerper
Melanie Leitner
Craig Boyce
Rist Brouwer
Dr. Robert Brown
Dr. Kuldip Dave
Dr. Merit Cudkowicz
Prof. Leonard van den Berg
Dr. Fernando Vieira
Dr. Alan Walts
Portfolio
Amylyx
Orphazyme
Emulate
Verge Genomics
Apic Bio
Prilenia
QurAlis
Bloom Science